Listed by the USPTO as LIPPERT, JOHN WILLIAM
Tech Center 3700 • Art Units: 1615 1621 1627 1638 1672 3772
This examiner grants 59% of resolved cases
LIPPERT, JOHN WILLIAM is a USPTO patent examiner in Tech Center 3700 and Art Unit 1615. The record includes 174 resolved cases, a 59.2% allowance rate, and a median of 1212 days to allowance. The allowance result indicates a modest majority of matters reached allowance, while the median timing supports planning for an extended prosecution cycle.
The interview lift is 39.9%, showing a strong association between interviews and allowance outcomes in the reported record. The listed companies are Trustees of Tufts College, University of Virginia Patent Foundation, and Dihesys Digital Health Systems. The listed firms are Nixon & Vanderhye, St. Onge Steward Johnston & Reens, and Amster Rothstein & Ebenstein. Interviews may be especially useful when paired with focused responses to outstanding rejections.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18670474 | CROSSLINKED HYDROGELS WITH TUNABLE RADIOPACITY FOR MEDICAL APPLICATIONS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18856605 | COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF | Non-Final OA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 18720092 | PROCESSES FOR PREPARING LIPID NANOPARTICLES | Non-Final OA | ModernaTX, Inc. |
| 18841466 | TISSUE DISPLACEMENT FOAM | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18290522 | USE OF ETHYNYLPYRIDINE COMPOUNDS AS NITRIFICATION INHIBITORS | Final Rejection | BASF SE |
| 18404760 | DRY EYE TREAMENT DEVICE | Non-Final OA | Verily Life Sciences LLC |
| 17996618 | LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18268472 | ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE | Non-Final OA | CORNELL UNIVERSITY |
| 18852262 | SYSTEMS AND METHODS UTILIZING THERANOSTIC AGENTS FOR BPCT AND BNCT FOR TARGETED CANCER TREATMENT | Non-Final OA | University of Virginia Patent Foundation |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | Final Rejection | University of Virginia Patent Foundation |
| 18720237 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | Final Rejection | L'OREAL |
| 18584761 | COMPOSITION INCLUDING A METAL-ORGANIC FRAMEWORK (MOF) NANOPARTICLE FOR ORAL PROTEIN ADMINISTRATION | Final Rejection | WUHAN UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy59.2% of resolved applications examined by John William Lippert were allowed (174 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +39.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by John William Lippert took 1,212 days on average from filing to allowance.
John William Lippert examines applications in Art Unit 1615 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
